NCT02878330: A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.
- State
- Completed
- Phase
- Phase 2
- People
- 1,453 taking part
- Started
- 3 Nov 2016
- Primary completion
- 17 Jul 2018
- Arms
- MEDI8897 50 mg
- Results
- Posted on the registry
- 25 Aug 2016: Trial registered
- 3 Nov 2016: Trial started
- 6 Dec 2018: Trial completed
- 14 Oct 2019: Trial results posted